FFA
AMGN icon

Freedman Financial Associates’s Amgen AMGN Stock Holding History

Freedman Financial Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-349
Closed -$85K – 24
2022
Q1 		$85K Buy
349
+24
+7% +$5.51K 0.06% 136
2021
Q4 		$73K Hold
325
– – 0.05% 155
2021
Q3 		$69K Hold
325
– – 0.05% 156
2021
Q2 		$79K Hold
325
– – 0.06% 137
2021
Q1 		$81K Hold
325
– – 0.07% 129
2020
Q4 		$75K Buy
+325
New +$74.9K 0.07% 126

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Freedman Financial Associates's AMGN Position: Q2 2022 in Review

Freedman Financial Associates sold out of Amgen (AMGN) in Q2 2022, closing a stake of 349 shares — an estimated $85K sold.

Freedman Financial Associates first reported a position in AMGN in Q4 2020 and held it in 6 quarters. The position peaked at $85K in Q1 2022. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

  • Freedman Financial Associates reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 349 Amgen shares in Q2 2022, an estimated $85K.
  • Freedman Financial Associates first reported a position in Amgen in Q4 2020 and held it in 6 quarters.
  • Freedman Financial Associates's Amgen position peaked at $85K in Q1 2022.
  • 2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.